beta-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer Disease Dream or Reality?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|1|2|175-186

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.1, Iss.2, 2001-07, pp. : 175-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disrupting &bgr;-Amyloid Aggregation for Alzheimer Disease Treatment

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 1, 2007-01 ,pp. : 115-126

Bentham Science Publishers

Access to resources Recommend Favorite

Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 – 2012)

By Belluti Federica   Rampa Angela   Gobbi Silvia   Bisi Alessandra  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 581-596

Informa Healthcare

Access to resources Recommend Favorite

Peptide Inhibitors of Beta Amyloid Aggregation

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 4, 2002-04 ,pp. : 417-423

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD)

By Lukiw Walter J  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 255-271

Informa Healthcare

Access to resources Recommend Favorite

Targeting Beta-Amyloid Pathogenesis Through Acetylcholinesterase Inhibitors

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4377-4387

Bentham Science Publishers

Access to resources Recommend Favorite